dbo:abstract
|
- Norpsilocin (4-HO-NMT) is tryptamine alkaloid recently discovered in 2017 in the psychedelic mushroom Psilocybe cubensis. It is hypothesized to be a dephosphorylated metabolite of baeocystin. Norpsilocin was found to be a full agonist of 5-HT2A receptor. It is also more potent than psilocin. (en)
|
dbo:casNumber
| |
dbo:chEMBL
| |
dbo:pubchem
| |
dbo:thumbnail
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 3020 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:c
| |
dbp:casNumber
| |
dbp:chembl
| |
dbp:chemspiderid
| |
dbp:drugName
| |
dbp:h
| |
dbp:iupacName
| |
dbp:n
| |
dbp:o
| |
dbp:pubchem
| |
dbp:smiles
| |
dbp:stdinchi
| |
dbp:stdinchikey
|
- MTJOWJUQGYWRHT-UHFFFAOYSA-N (en)
|
dbp:synonyms
|
- 4 (xsd:integer)
- (en)
- AS-63499 (en)
|
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
rdf:type
| |
rdfs:comment
|
- Norpsilocin (4-HO-NMT) is tryptamine alkaloid recently discovered in 2017 in the psychedelic mushroom Psilocybe cubensis. It is hypothesized to be a dephosphorylated metabolite of baeocystin. Norpsilocin was found to be a full agonist of 5-HT2A receptor. It is also more potent than psilocin. (en)
|
rdfs:label
| |
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:isPrimaryTopicOf
| |
foaf:name
| |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |